Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

Clear
Q1
MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q1
MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Copyright/Patent/Trademark, Trade (domestic/foreign), Pharmacy, Budget/Appropriations
View →
Q1
MARSHALL & POPP, LLC for PFIZER, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Budget/Appropriations, Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
MARSHALL & POPP, LLC for GENENTECH, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
MARSHALL & POPP, LLC for AMGEN USA INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Trade (domestic/foreign), Budget/Appropriations, Pharmacy, Copyright/Patent/Trademark
View →
Q1
WALGREEN COMPANY for WALGREEN COMPANY
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Consumer Issues/Safety/Products, Taxation/Internal Revenue Code, Pharmacy
View →
Q1
BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q1
CROSSROADS STRATEGIES, LLC for INDIVIOR INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
POLARIS GOVERNMENT RELATIONS, LLC for CIGNA CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Pharmacy
View →
Q1
SALT POINT STRATEGIES for VERTEX PHARMACEUTICALS
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $30,000.00 income
Pharmacy
View →
Q1
ARENTFOX SCHIFF LLP for AMERICAN PHARMACY COOPERATIVE, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Alabama · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
BL PARTNERS GROUP, LLC for ALBERTSONS COMPANIES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $50,000.00 income
Agriculture, Food Industry (safety, labeling, etc.), Pharmacy
View →
Q1
RADIUS ADVOCACY, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Copyright/Patent/Trademark, Pharmacy
View →
Q1
RADIUS ADVOCACY, LLC for HEALTHCARE DISTRIBUTION ALLIANCE
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
2359 STRATEGIES for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $12,000.00 income
Medicare/Medicaid, Health Issues, Medical/Disease Research/Clinical Labs, Pharmacy
View →
Q1
OREGON HEALTH & SCIENCE UNIVERSITY for OREGON HEALTH & SCIENCE UNIVERSITY
1st Quarter (Jan 1 - Mar 31) 2025 · Oregon · House · Senate
Pharmacy, Education, Indian/Native American Affairs, Budget/Appropriations
View →
Q1
DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy
View →
Q1
K&L GATES, LLP for AGC AMERICA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $90,000.00 income
Science/Technology, Environment/Superfund, Pharmacy
View →
Q1
W STRATEGIES, LLC for PHLOW CORP.
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
W STRATEGIES, LLC for OTSUKA AMERICA PHARMACEUTICAL, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · $50,000.00 income
Pharmacy
View →
1T
W STRATEGIES, LLC for MCKESSON CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · California · $10,000.00 income
Pharmacy
View →
Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for CENCORA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · Senate · $60,000.00 income
Health Issues, Pharmacy
View →
RR
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia
Science/Technology, Taxation/Internal Revenue Code, Health Issues, Pharmacy
View →
Q1
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
LINCOLN PARK GROUP L.L.C. for CANADIAN INTERNATIONAL PHARMACY ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $40,000.00 income
Pharmacy
View →
Previous Page 65 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem